John Barrington, MD
Adult Reconstructive Orthopaedic Surgery · Plano, TXNPI 1336120328
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $1,592,373 of the $2,195,433 with a category attached, or 72.5%. 20 manufacturers reported payments, led by Zimmer Biomet at 30.4% of the total. Reporting peaked in 2019 at $651,444 and has fallen 52.0% since, to $312,540 in 2025. Among adult reconstructive orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 663 payments — averaging $3311.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$667K
- Smith+Nephew$608K
- Encore Medical, LP$561K
- Pacira Therapeutics, Inc.$306K
- Kyocera Medical Technologies, Inc.$28K
- Pacira Pharmaceuticals Incorporated$17K
- plus $8K from 14 others
What the payments were for
- Royalty or licence$1,592,37373%
- Consulting fees$272,41612%
- Speaking & faculty fees$256,62512%
- Travel & lodging$65,3143%
- Food & beverage$8,6800%
- Education$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 129 | $667,232 |
| Smith+Nephew | 71 | $608,107 |
| Encore Medical, LP | 162 | $560,670 |
| Pacira Therapeutics, Inc. | 261 | $306,319 |
| Kyocera Medical Technologies, Inc. | 7 | $27,967 |
| Pacira Pharmaceuticals Incorporated | 10 | $17,097 |
| AstraZeneca | 1 | $4,080 |
| Medical Device Business Services, Inc. | 1 | $2,750 |
| Shalby Advanced Technologies, Inc. | 2 | $376 |
| Maxx Orthopedics, Inc. | 3 | $253 |
| Vertex | 2 | $173 |
| Biotronik NRO, Inc. | 1 | $129 |
| Johnson & Johnson | 5 | $73 |
| Orthalign Inc | 1 | $73 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| Axogen | 1 | $25 |
| Innovation Technologies Inc | 1 | $21 |
| Molnlycke Health Care US, LLC | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Theragen, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$843,854
- DJO SURGICAL$686,166
- Arcos$562,289
- Zilretta$304,466
- Oxford$43,152
- Oxford-Knees$37,200
- DJO Surgical Exprt Revision Hip$27,479
- Arcos Revision Hip Instrumentation$22,883
- EXPAREL$19,733
- DJO Surgical TaperFill Hip System$19,500
- JII Unicondylar Knee System$17,772
- DJO Surgical FMP Acetabular System$14,859
- DJO Surgical Empowr Knee System$14,680
- DJO Surgical Linear Hip System$12,900
- Iovera$9,733
- ANDEXXA$4,080
- DJO Surgical Exprt Revision Knee$1,041
- DJO Surgical 3DKnee System$759
- ZUK Uni$738
- DJO Surgical CLP Hip System$725
How this compares
$2,195,433 in reported general payments places this provider in the 95th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.
See all adult reconstructive orthopaedic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 248 | $1,758 |
| Dexamethasone | 280 | $1,494 |
| Ondansetron Hcl | 221 | $1,432 |
| Tramadol Hcl | 248 | $1,270 |
| Cephalexin | 293 | $1,156 |
| Tranexamic Acid | 34 | $804 |
| Ondansetron OdtOndansetron | 31 | $447 |
| Amoxicillin | 175 | $408 |
| Celecoxib | 28 | $402 |
| Ibuprofen | 46 | $248 |
| Clindamycin Hcl | 47 | $135 |
| Gabapentin | 26 | $121 |
| Meloxicam | 32 | $80 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Plano
- Roger EmersonPlano$691K
- Richard ReitmanPlano$227K
- Kwame EnninPlano$132K
- Tyler GoldbergAustin$4.6M
- Antonia ChenDallas$3.8M
- Donald HohmanDallas$537K
- Steven WeedenFort Worth$370K
- Marcus FordFort Worth$296K
- Raul MarquezEdinburg$278K
- Brian FullerCarrollton$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.